Absence of mutations in the ATM gene in forty-seven cases of sporadic breast cancer

British Journal of Cancer

Volumn 80, Issue 12, 1999, Pages 1979-1981

  Bebb, D G ^a,b,c   Yu, Z ^a   Chen, J ^a   Telatar, M ^d   Gelmon, K ^b   Phillips, N ^b   Gatti, R A ^d   Glickman, B W ^a  

^a UNIVERSITY OF VICTORIA   (Canada)

^b BRITISH COLUMBIA CANCER RESEARCH CENTRE   (Canada)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Ataxia telangiectasia; Breast cancer; Cancer predisposition; Protein truncation test (PTT)

Indexed keywords

ADULT; AGED; ARTICLE; ATAXIA TELANGIECTASIA; BREAST CANCER; CANCER RISK; CANCER SUSCEPTIBILITY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE MUTATION; GENETIC ASSOCIATION; HETEROZYGOTE; HUMAN; HUMAN CELL; ONSET AGE; POPULATION GENETICS; PRIORITY JOURNAL;

ADULT; AGE OF ONSET; AGED; ATAXIA TELANGIECTASIA; BREAST NEOPLASMS; CELL CYCLE PROTEINS; DNA-BINDING PROTEINS; FEMALE; HETEROZYGOTE DETECTION; HUMANS; MIDDLE AGED; MUTATION; POLYMERASE CHAIN REACTION; PROTEIN-SERINE-THREONINE KINASES; PROTEINS; RNA; SENSITIVITY AND SPECIFICITY; TUMOR SUPPRESSOR PROTEINS;

EID: 0032778345     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6690630     Document Type: Article

References (33)

1. Athma P, Rappaport R and Swift M (1996) Molecular genotyping shows that ataxia-telangiectasia heterozygotes are predisposed to breast cancer. Cancer Genet Cytogenet 92: 130-134
2. Bebb G, Steele PP, Warrington PJ, Moffat JA and Glickman BW (1998) Caffeine does not potentiate radiation induced DNA damage in ataxia-telangiectasia lymphoblastoid cells. Mutat Res 401: 27-32
3. Bhatia S, Robison LL, Oberlin O, Greenberg M, Bunin G, Fossati-Bellani F and Medows AT (1996) Breast and other second neoplasms after childhood Hodgkin's disease. N Engl J Med 334: 745-751
4. Borresen AL, Anderson TI, Treti S, Heiberg A and Moller P (1990) Breast cancer and other cancers in Norwegian families with ataxia-telangiectasia. Genes Chromosomes Cancer 2: 339-340
5. Broca PP (1866) Traites des tumeurs 1: 80
6. Chen J, Birkholtz GG, Lindblom P, Rubio C and Lindblom A (1998) The role of ataxia-telangiectasia in familial breast cancer. Cancer Res 58: 1376-1379
7. Easton DF (1994) Cancer risks in A-T heterozygotes. Int J Radiat Biol 66: S177-182
8. Fitzgerald MG, Bean JM, Hegde SR, Unsal H, MacDonald DJ, Harkin DP, Finkelstein DM, Isselbacher KJ, and Haber DA (1997) Heterozygous ATM mutations do not contribute to early onset of breast cancer. Nat Genet 15: 307-310
9. Ford D and Easton DF (1995) The genetics of breast and ovarian cancer. Br J Cancer 72: 805-812
10. Gatti RA (1998) Ataxia telangiectasis. In: The Genetic Basis of Human Cancers, Vogelstein B and Kingley KW (eds.). pp. 275 300, McGraw-Hill: New York
11. Gilad S, Khosravi R, Shkedy D, Uziel T, Ziv Y, Savitsky K, Rotman G, Smith S, Chessa L, Jorgensen TJ, Harnik R, Frydman M, Sanal O, Portnoi S, Goldwicz Z, Jaspers NGJ, Gatti R, Lenoir G, Lavin M, Tatsumi K, Wegner RD, Shiloh Y and Bar-Shira A (1996) Predominance of null mutations in ataxia-telangiectasia. Hum Mol Genet 5: 433-439
12. Heim RA, Lench NJ and Swift M (1992) Heterozygous manifestations in four autosomal recessive cancer-prone syndromes, ataxia telangiectasia, xeroderma pigmentosum, Fanconi anemia and Bloom syndrome. Mutat Res 284: 25-36
13. Kinzler KW and Vogelstein B (1997) Gatekeepers and caretakers. Nature 386: 761-762
14. Lavin ME, Bennett I, Ramsay J, Gardiner RA, Seymor GJ, Farrell A and Walsh M (1994) Identification of a potentially sensitive subgroup among patients with breast cancer. J Natl Cancer Inst 86: 1627-1634
15. Lynch HT, Mulchahy GM and Lynch P (1976) Genetic factors in breast cancer, a survey. Pathol Ann 11: 77-101
16. Lynch HT, Smyrk T and Lynch J (1997) An update of HNPCC, Lynch syndrome. Cancer Genet Cytogenet 93: 84-99
17. Norman A, Iwamoto KS, Kagan AR and Wollin M (1992) Radiation sensitive breast cancer patients. Radiother Oncol 23: 196-197
18. Pippard EC, Hall AJ, Barker DJ and Bridges BA (1988) Cancer in homozygotes and heterozygotes of ataxia telangiectasia and xeroderma pigmentosum in Britain. Cancer Res 48: 2929-2932
19. Savitsky K, Bar-Shira A, Gilad S, Rotman G, Ziv Y, Vanagaite L, Tagle DA, Smith S, Uziel T, Sfez S, Ashkenazi M, Pecker I, Frydman M, Harnik R, Patanjali SR, Simmons A, Clines GA, Sartiel A, Gatti RA, Chessa L, Sanal O, Lavin MF, Jaspers NGJ, Taylor AMR, Arlett CF, Miki T, Weissman SM, Lovett M, Collins FS and Shiloh Y (1995) A single ataxia-telangiectasia gene with a product similar to PI-3 kinase. Science 268: 1749-1753
20. Scott D, Jones LA, Elyan SAG, Spreadborough A, Cowan R and Rihiero G (1993) Identification of AT-heterozygotes. In: Ataxia-Telangiectasia, Gatti RA and Palmer RB (eds.), pp. 101-116. NATO ASI Series vol H 77
21. Scott D, Barber JBP, Levine EL, Burrill W and Roberts SA (1998) Radiation-induced micronucleus induction in lymphocytes identifies a high frequency of radiosensitive cases among breast cancer patients - a test for predisposition. Br J Cancer 77: 614-620
22. Scully R, Chen J, Plug A, Xiao Y, Weaver D, Feunteun J, Ashley T and Livingston DM (1997) Association of Brcal with Rad51 in mitotic and meiotic cells. Cell 88: 265-275
23. Serova OM, Mazoyer S, Puget N, Dubois V, Tonin P, Shugart YY, Goldgar D, Narod SA, Lynch HT and Lenoirm GM (1997) Mutations in Brea1 and Brea2 in breast cancer families, are there more breast cancer-susceptibility genes? Am J Hum Genet 60(3): 486-495
24. Sharan SK, Morimatsti M, Albrecht U, Lim DS, Regel K, Dinh C, Sands A, Eichele G, Hasty P and Bradley A (1997) Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking Brea2. Nature 386: 804-810
25. Stankovic T, Kidd AMJ, Sutcliffe A, Meguire GM, Robinson P, Weber P, Bedenham T, Bradwell AR, Easton DF, Lennox GG, Haites N, Byrd PJ and Taylor AMR (1998) ATM mutations and phenotypes in ataxia-telangiectasia families in the British Isles - expression of mutant ATM and the risk of leukemia, lymphoma and breast cancer. Am J Hum Genet 62: 334-345
26. Swift M, Sholman L, Perry M and Chase C (1976) Malignant neoplasms in the families of patients with ataxia-telangiectasia. Cancer Res 36: 209-215
27. Swift M, Morrell D, Massey RB and Chase CL (1991) Incidence of cancer in 161 families affected by ataxia-telangiectasia. N Engl J Mec 325: 1831-1836
28. Telatar M, Wang Z, Udar N, Liang T, Bernatowska-Matuszkewicz E, Lavin M, Shiloh Y, Concannon P, Good RA and Gatti RA (1996) Ataxia-telangiectasia, mutations in ATM cDNA detected by protein truncation screening. Am J Hum Genet 59: 40-44
29. Telatar M, Teraoka S, Wang ZJ, Chun HH, Liang T, Castellvibel S, Udar N, Borresendale AL, Chessa L, Bernatowska Matuszkiewicz E, Porras O, Watanabe M, Junder A, Concannon P and Gatti RA (1998) Ataxia-telangiectasia - identification and detection of founder effect mutations in the ATM gene in ethnic populations. Am J Hum Genet 62: 86-97
30. Telatar M, Wang Z, Castellvi BeI S, Tai L-Q, Rivero-Carmena M, Regueiro JR, Porras O and Gatti RA (1999) A model for ATM heterozygote identification in a large population. Four founder effect ATM mutations identify most of Costa Rican patients with ataxia-telangiectasia. Mol Genet Metab (in press)
31. Tokunga M, Land CE and Yamamoto T (1987) Incidence of breast cancer among atomic bomb survivors, Hiroshima and Nagasaki, 1950-1980. Radiat Res 112: 243-272
32. Vorechovsky I, Luo L, Dyer MJS, Catovsky D, Amlot P, Yaxley JC, Foroni L, Hammarstrom L, Webster ADB and Yuille M (1997) Clustering of missense mutations in the ataxia-telangiectasia gene in sporadic T-cell leukaemia. Nat Genet 17: 96-99
33. Yuille MAR, Coignet LJA, Abraham SM, Yaqub F, Luo L, Matutes E, Britobabapulle V, Vorechovsky I, Dyer MJS and Catovsky D (1998) ATM is usually rearranged in T cell prolymphocytic leukaemia. Oncogene 16: 789-796